| Dr Kateryna Kiselova, DO | |
|
1690 Big Oak Rd, Yardley, PA 19067-6421 | |
| (215) 736-9362 | |
| Not Available |
| Full Name | Dr Kateryna Kiselova |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 10 Years |
| Location | 1690 Big Oak Rd, Yardley, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639580509 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 25MB10696300 (New Jersey) | Secondary |
| 207Q00000X | Family Medicine | OS018475 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Home Health | Springfield, PA | Home health agency |
| Capital Health Medical Center - Hopewell | Pennington, NJ | Hospital |
| Hospital Of Univ Of Pennsylvania | Philadelphia, PA | Hospital |
| St Mary Medical Center | Langhorne, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capital Health Medical Group | 7618264532 | 364 |
| Capital Health Medical Group | 7618264532 | 364 |
News Archive
With the potential to save tens of thousands of lives each year, a new cost-effective rabies therapy developed by MassBiologics at the University of Massachusetts and the Serum Institute of India took an important step forward with positive results from a Phase 1 study. The recently completed study showed that a new monoclonal antibody (RAB-1) resulted in protective antibody levels in the serum of treated subjects equal to the current standard of treatment, which is often not available in the areas of the world hit hardest by rabies.
Obstetric interventions during an Ebola epidemic are deeply challenging say two new commentaries published today (14 January) in BJOG: An International Journal of Obstetrics and Gynaecology (BJOG).
Scientists at the Francis Crick Institute and UCL have identified the trigger of a key cellular change in amyotrophic lateral sclerosis (ALS), a type of motor neurons disease.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that enrollment and treatment of patients in a Phase 1b clinical trial has been initiated to evaluate JX-594 in patients with advanced metastatic, refractory colorectal cancer (CRC).
› Verified 2 days ago
| Entity Name | Clinical Care Associates Of The University Of Pennsylvania Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972682995 PECOS PAC ID: 4688588866 Enrollment ID: O20031113000301 |
News Archive
With the potential to save tens of thousands of lives each year, a new cost-effective rabies therapy developed by MassBiologics at the University of Massachusetts and the Serum Institute of India took an important step forward with positive results from a Phase 1 study. The recently completed study showed that a new monoclonal antibody (RAB-1) resulted in protective antibody levels in the serum of treated subjects equal to the current standard of treatment, which is often not available in the areas of the world hit hardest by rabies.
Obstetric interventions during an Ebola epidemic are deeply challenging say two new commentaries published today (14 January) in BJOG: An International Journal of Obstetrics and Gynaecology (BJOG).
Scientists at the Francis Crick Institute and UCL have identified the trigger of a key cellular change in amyotrophic lateral sclerosis (ALS), a type of motor neurons disease.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that enrollment and treatment of patients in a Phase 1b clinical trial has been initiated to evaluate JX-594 in patients with advanced metastatic, refractory colorectal cancer (CRC).
› Verified 2 days ago
| Entity Name | Capital Health Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437516887 PECOS PAC ID: 7618264532 Enrollment ID: O20161007001348 |
News Archive
With the potential to save tens of thousands of lives each year, a new cost-effective rabies therapy developed by MassBiologics at the University of Massachusetts and the Serum Institute of India took an important step forward with positive results from a Phase 1 study. The recently completed study showed that a new monoclonal antibody (RAB-1) resulted in protective antibody levels in the serum of treated subjects equal to the current standard of treatment, which is often not available in the areas of the world hit hardest by rabies.
Obstetric interventions during an Ebola epidemic are deeply challenging say two new commentaries published today (14 January) in BJOG: An International Journal of Obstetrics and Gynaecology (BJOG).
Scientists at the Francis Crick Institute and UCL have identified the trigger of a key cellular change in amyotrophic lateral sclerosis (ALS), a type of motor neurons disease.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that enrollment and treatment of patients in a Phase 1b clinical trial has been initiated to evaluate JX-594 in patients with advanced metastatic, refractory colorectal cancer (CRC).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kateryna Kiselova, DO 1445 Whitehorse Mercerville Road, Suite 103, Hamilton, NJ 08619-3834 Ph: (609) 587-6661 | Dr Kateryna Kiselova, DO 1690 Big Oak Rd, Yardley, PA 19067-6421 Ph: (215) 736-9362 |
News Archive
With the potential to save tens of thousands of lives each year, a new cost-effective rabies therapy developed by MassBiologics at the University of Massachusetts and the Serum Institute of India took an important step forward with positive results from a Phase 1 study. The recently completed study showed that a new monoclonal antibody (RAB-1) resulted in protective antibody levels in the serum of treated subjects equal to the current standard of treatment, which is often not available in the areas of the world hit hardest by rabies.
Obstetric interventions during an Ebola epidemic are deeply challenging say two new commentaries published today (14 January) in BJOG: An International Journal of Obstetrics and Gynaecology (BJOG).
Scientists at the Francis Crick Institute and UCL have identified the trigger of a key cellular change in amyotrophic lateral sclerosis (ALS), a type of motor neurons disease.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that enrollment and treatment of patients in a Phase 1b clinical trial has been initiated to evaluate JX-594 in patients with advanced metastatic, refractory colorectal cancer (CRC).
› Verified 2 days ago
Dr. Joseph Chun-fu Huang, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 777 Township Line Rd, Yardley, PA 19067 Phone: 215-860-0775 | |
Dr. Patrice L Taylor, D.O., D.A.B.A.M. Family Medicine Medicare: Medicare Enrolled Practice Location: 301 Oxford Valley Rd, Suite 1904, Yardley, PA 19067 Phone: 267-392-5200 Fax: 267-392-5207 | |
Dr. David Francis Ladley, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 301 Oxford Valley Rd., Suite 202b, Yardley, PA 19067 Phone: 607-743-6162 Fax: 804-477-8370 | |
Dr. Patrick M Adler, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 Oxford Valley Rd, Suite 1000, Yardley, PA 19067 Phone: 267-503-0130 Fax: 267-503-0127 | |
Dr. Justin Palatt, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 Oxford Valley Rd, Yardley, PA 19067 Phone: 267-503-0130 Fax: 267-503-0122 | |
Charles O Dougherty, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 62 South Main Street, Yardley, PA 19067 Phone: 215-493-5535 | |
Patti B Garbeil, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 407 Lenape Ln, Yardley, PA 19067 Phone: 215-493-1150 |